Metastatic Breast Cancer 2025 UPDATE
Two Onc Docs
00:00
Second-Line Options for ER/PR-Positive Disease
Kareen reviews repeat molecular testing, targeted agents like alpelisib, capivasertib, everolimus, and chemotherapy and ADC choices including T-DXd.
Play episode from 04:28
Transcript
